Join the DDA or

PI recalls due to integrity concerns

Products with unknown origin

September 17th 2020

Tagged: MHRA alert

By MHRA

Medicines from the following parallel distributors are being recalled due to concerns that the supply chain may have been compromised and the origins of the products are unknown.

  • Beachcourse
  • Orifarm A/S
  • OPD Laboratories
  • Strathclyde Pharmaceuticals
  • Quadrant Pharmaceuticals
  • Lexon UK

Affected products are as follows:

Beachcourse 

ProductEU ref numberPack SizeBatch NumberExpiry Date
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285801712310/2021

 Orifarm A/S

ProductEU ref numberPack SizeBatch NumberExpiry Date
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5629162109/2024
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5629585112/2024
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5629621210/2024

 OPD Laboratories

ProductEU ref numberPack SizeBatch NumberExpiry Date
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5625858206/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5625924906/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5626786208/2023

 Strathclyde Pharmaceuticals (repacked by Munro Wholesale Medical Supplies)

ProductEU ref numberPack SizeBatch NumberExpiry Date
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5626752510/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5626786208/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5626786310/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5626310008/2023
Vimpat 100mg TabletsEU/1/08/470/004 or EU/1/05/331/00514 or 5625858206/2023
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285803310103/2022

 Quadrant Pharmaceuticals (repacked by Maxearn)

ProductEU ref numberPack SizeBatch NumberExpiry Date
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285803310103/2022

Lexon (UK)

ProductEU ref numberPack SizeBatch NumberExpiry Date
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285801712310/2021
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285803010201/2022
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285803310303/2022
Neupro 4mg/24 hour Transdermal PatchesEU/1/05/331/004 or EU/1/05/331/0057 or 285803710104/2022

Healthcare professionals should quarantine all stock from the affected batches – the name of the parallel distributor/repacker can be found on the product packaging – and return it to your supplier.

Please note that there is no suggestion at this time that any of the UK parallel distributors have knowingly purchased or onward-supplied medicines that they knew or believed to be falsified.